05.06.
16:04
-
www.zacks.com
Biogens Salanersen secures FDA Breakthrough Therapy designation for SMA after phase Ib data showed motor gains and supports once-yearly dosing.
25.05.
15:27
-
www.zacks.com
OXY is above its 200-day SMA, with Permian growth, CrownRock assets and a Bandit discovery, yet Middle East disruptions could
21.05.
16:44
-
www.fool.com
Image source: The Motley Fool.DATEThursday, May 21, 2026 at 11 a.m. ETCALL PARTICIPANTSCo-Chief Executive Officer — Erik R. HirschChief Financial
21.05.
16:07
-
www.zacks.com
ETN trades above its 200-day SMA as backlog jumps and AI data-center demand boosts growth, yet a premium valuation may
15.05.
00:00
-
www.zacks.com
KGC slipped below its 50-day SMA as gold prices weakened, but strong cash flow, project growth and a solid balance
13.05.
18:24
-
www.zacks.com
ASML trades above its 50-day SMA as AI-driven chip demand supports strong guidance and a solid order backlog, despite a
07.05.
22:20
-
www.fool.com
Image source: The Motley Fool.DateMay 7, 2026Call participantsPresident and Chief Executive Officer — Ian MortimerChief Medical Officer — Christopher John